| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4568159
Max Phase: Preclinical
Molecular Formula: C20H17ClFN3S
Molecular Weight: 385.90
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: Fc1ccc(CCNCc2c(-c3ccc(Cl)cc3)nc3sccn23)cc1
Standard InChI: InChI=1S/C20H17ClFN3S/c21-16-5-3-15(4-6-16)19-18(25-11-12-26-20(25)24-19)13-23-10-9-14-1-7-17(22)8-2-14/h1-8,11-12,23H,9-10,13H2
Standard InChI Key: JNRCIIHAOUDRAR-UHFFFAOYSA-N
Associated Targets(Human)
Nuclear receptor subfamily 1 group I member 3 655 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 385.90 | Molecular Weight (Monoisotopic): 385.0816 | AlogP: 5.19 | #Rotatable Bonds: 6 |
| Polar Surface Area: 29.33 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
| #RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: 9.48 | CX LogP: 5.06 | CX LogD: 3.01 |
| Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.46 | Np Likeness Score: -1.99 |
References
| 1. Liang D, Li L, Lynch C, Mackowiak B, Hedrich WD, Ai Y, Yin Y, Heyward S, Xia M, Wang H, Xue F.. (2019) Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies., 179 [PMID:31247375] [10.1016/j.ejmech.2019.06.031] |
Source
Source(1):